Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Community case study for surveillance and early case-detection of SARS-CoV-2 infections across high-risk key populations: the Sentinella programme.
Tebon M, Davis RJ, Savoldi A, Soriolo N, Walters SEJ, Nosè M, Barbui C, Turrini G, Danese E, Lippi G, Cecchetto R, Mazzariol A, Gibellini D, Caliskan G, Marchetti P, Verlato G, Princivalle A, Porru S, Tacconelli E, De Nardo P. Tebon M, et al. Among authors: savoldi a. Front Public Health. 2024 Oct 23;12:1432157. doi: 10.3389/fpubh.2024.1432157. eCollection 2024. Front Public Health. 2024. PMID: 39512710 Free PMC article.
Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern.
Mazzaferri F, Mirandola M, Savoldi A, De Nardo P, Morra M, Tebon M, Armellini M, De Luca G, Calandrino L, Sasset L, D'Elia D, Sozio E, Danese E, Gibellini D, Monne I, Scroccaro G, Magrini N, Cattelan A, Tascini C; MANTICO Working Group; Tacconelli E. Mazzaferri F, et al. Among authors: savoldi a. Elife. 2022 Nov 22;11:e79639. doi: 10.7554/eLife.79639. Elife. 2022. PMID: 36413383 Free PMC article. Clinical Trial.
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments.
Gupta A, Konnova A, Smet M, Berkell M, Savoldi A, Morra M, Van Averbeke V, De Winter FH, Peserico D, Danese E, Hotterbeekx A, Righi E; mAb ORCHESTRA working group; De Nardo P, Tacconelli E, Malhotra-Kumar S, Kumar-Singh S. Gupta A, et al. Among authors: savoldi a. J Clin Invest. 2023 Mar 15;133(6):e166032. doi: 10.1172/JCI166032. J Clin Invest. 2023. PMID: 36727404 Free PMC article.
Diagnostic Accuracy of a Rapid SARS-CoV-2 Antigen Test Among People Experiencing Homelessness: A Prospective Cohort and Implementation Study.
De Nardo P, Tebon M, Savoldi A, Soriolo N, Danese E, Peserico D, Morra M, Gentilotti E, Caliskan G, Marchetti P, Cecchetto R, Mazzariol A, Verlato G, Gibellini D, Tacconelli E. De Nardo P, et al. Among authors: savoldi a. Infect Dis Ther. 2023 Apr;12(4):1073-1082. doi: 10.1007/s40121-023-00787-0. Epub 2023 Mar 13. Infect Dis Ther. 2023. PMID: 36907951 Free PMC article.
Assessment of COVID-19 progression on day 5 from symptoms onset.
Gentilotti E, Savoldi A, Compri M, Górska A, De Nardo P, Visentin A, Be G, Razzaboni E, Soriolo N, Meneghin D, Girelli D, Micheletto C, Mehrabi S, Righi E, Tacconelli E. Gentilotti E, et al. Among authors: savoldi a. BMC Infect Dis. 2021 Aug 28;21(1):883. doi: 10.1186/s12879-021-06596-5. BMC Infect Dis. 2021. PMID: 34454452 Free PMC article.
Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression: a prospective cohort study.
Savoldi A, Morra M, De Nardo P, Cattelan AM, Mirandola M, Manfrin V, Scotton P, Giordani MT, Brollo L, Panese S, Lanzafame M, Scroccaro G, Berkell M, Lippi G, Konnova A, Smet M, Malhotra-Kumar S, Kumar-Singh S, Tacconelli E; mAb Working Group. Savoldi A, et al. Eur J Clin Microbiol Infect Dis. 2022 Jul;41(7):1065-1076. doi: 10.1007/s10096-022-04464-x. Epub 2022 Jun 21. Eur J Clin Microbiol Infect Dis. 2022. PMID: 35727429 Free PMC article.
Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy.
Ciccimarra F, Luxi N, Bellitto C, L' Abbate L, De Nardo P, Savoldi A, Yeomans A, Molokhia M, Tacconelli E, Trifirò G. Ciccimarra F, et al. Among authors: savoldi a. BioDrugs. 2023 Sep;37(5):675-684. doi: 10.1007/s40259-023-00601-w. Epub 2023 May 6. BioDrugs. 2023. PMID: 37148526 Free PMC article.
54 results